Fowl Cholera in Poultry: Etiology, Diagnosis, and Control

Introduction

Fowl cholera, also known as avian pasteurellosis, is a highly contagious bacterial disease affecting domestic poultry, wild birds, and waterfowl worldwide [1, 2]. The disease is caused by the Gram-negative coccobacillus Pasteurella multocida [3, 4]. Outbreaks of fowl cholera result in significant economic losses due to high morbidity and mortality, decreased egg production, and the costs associated with treatment and control measures [5, 6]. The disease can manifest in peracute, acute, or chronic forms depending on host susceptibility, strain virulence, and environmental stressors [2, 7].

Etiology

The Causative Agent: Pasteurella multocida

The fowl cholera bacterial agent, P. multocida, is a nonmotile, facultatively anaerobic, bipolar-staining Gram-negative rod belonging to the family Pasteurellaceae [8, 9]. Capsular serogroups A, B, D, E, and F are recognized based on capsular antigens, with serogroup A being the most common cause of fowl cholera in poultry [10, 9]. The lipopolysaccharide (LPS) outer core of the bacterium is a critical virulence determinant, and isolates are further classified into eight LPS genotypes (L1 through L8) based on outer core biosynthesis loci [9, 11, 12].

The genome of P. multocida is approximately 2.3 to 2.5 Mb in size and encodes a range of virulence factors, including adhesins, toxins, iron acquisition systems, and a polysaccharide capsule [13, 14, 15]. The hyaluronic acid capsule, encoded by the hyaD gene cluster, is a key antiphagocytic component [14, 15]. Strains deficient in capsule production exhibit reduced virulence in avian models [15].

Virulence Factors

P. multocida possesses multiple molecular determinants of pathogenicity. The polysaccharide capsule inhibits phagocytosis and complement-mediated killing [14]. Lipopolysaccharide contributes to serum resistance and induces a strong inflammatory response [12]. The filamentous hemagglutinin (FhaB) and other adhesins facilitate attachment to host respiratory epithelial cells [16]. The P. multocida toxin (PMT), encoded by the toxA gene, is a potent mitogen that activates intracellular signaling cascades, leading to cellular proliferation and immune modulation [17]. While PMT is classically associated with atrophic rhinitis in swine, its role in avian fowl cholera pathogenesis remains variable depending on the host species and strain [17]. Iron acquisition systems, including receptors for hemin and transferrin, are essential for bacterial survival within the avian host [8, 14].

Phase variation in LPS glycosyltransferase genes is a documented mechanism of immune evasion in P. multocida strains associated with outbreaks on free-range layer farms [11]. This reversible, high-frequency switching of surface carbohydrate structures allows the bacterium to evade host antibody responses and persist in carrier birds [11].

Epidemiology

Fowl cholera occurs in all poultry-producing regions of the world [3, 4]. Domestic chickens, turkeys, ducks, and geese are all susceptible [18, 10, 19]. Turkeys and waterfowl are generally more susceptible to acute disease than chickens [2, 19]. A 100% mortality rate has been documented in commercial slow-growing broiler chickens during acute fowl cholera outbreaks [2].

The primary source of infection is carrier birds that harbor P. multocida in their upper respiratory tracts or oropharyngeal tonsils [20, 4]. Transmission occurs via direct contact between infected and susceptible birds, through contaminated feed and water, and by inhalation of aerosolized droplets [3, 4]. Fomites, contaminated equipment, and footwear can also spread the organism between flocks [1, 5].

Environmental and management factors influence the occurrence of fowl cholera. Brucellosis coinfection and interactions with mycoplasmas can exacerbate disease severity [18]. Land cover and farm location may influence outbreak risk through exposure to wild bird reservoirs [20]. A compartmental model of fowl cholera transmission in poultry farms demonstrated that biosecurity measures and early detection are critical for controlling disease spread [1].

In the context of regional nomenclature, the fowl cholera bacterial disease is referred to as मुर्गी हैजा (murgi haiza) in Hindi (fowl cholera in hindi), reflecting its clinical similarity to classic cholera in terms of rapid-onset diarrhea and septicemia.

Clinical Signs

The clinical presentation of fowl cholera varies with the course of disease [4]. In the peracute form, birds are found dead without premonitory signs [2]. Mortality can spike rapidly, with no observed illness before death [2].

Acute fowl cholera is characterized by fever (elevated body temperature), depression, anorexia, ruffled feathers, cyanosis of the comb and wattles, and mucoid or bloody diarrhea [4, 7]. Respiratory signs, including cough, dyspnea, and rales, are common due to the involvement of the respiratory tract [18]. In chickens, oral discharge and swelling of the wattles (wattle edema) are frequently observed [2, 4].

Chronic fowl cholera typically develops after an acute outbreak or in flocks with partial immunity [4]. Clinical signs include localized infections such as swollen joints (arthritis), sternal bursitis, torticollis from otitis media, and chronic respiratory disease [4, 5]. Conjunctivitis and sinusitis are also reported, particularly in turkeys [18, 10].

Pathology

Gross Lesions

Peracute cases may lack gross lesions [2]. In acute fowl cholera, gross lesions are those of a fulminant septicemia. Petechial and ecchymotic hemorrhages are found on the epicardium, serosal membranes, and abdominal fat [2, 7]. The liver is friable with multifocal pinpoint necrotic foci of a pale yellow color [4, 7]. The spleen is enlarged and congested. The lungs may be congested or edematous, with fibrinous pneumonia in some cases [18, 19].

In chronic fowl cholera, lesions are localized. Caseous exudate is present in the infraorbital sinuses, wattles, joints, and tympanic cavities [4]. Fibrinous pericarditis and airsacculitis are common findings in turkeys [10].

Histopathology

Histologically, acute cases demonstrate acute fibrinous pneumonia, multifocal hepatic necrosis with heterophilic infiltration, and splenic lymphoid depletion [7]. Fibrin thrombi are present in small vessels [19]. In chronic cases, pyogranulomatous inflammation with central caseous necrosis and peripheral fibroplasia is observed in affected joints and sinuses [4].

Diagnosis

A definitive diagnosis of fowl cholera requires isolation and identification of P. multocida from clinical specimens [3, 4]. Samples from acutely affected birds include heart blood, liver, spleen, and bone marrow. In chronic cases, swabs of exudate from wattles, sinuses, or joints are appropriate [4].

Conventional Diagnostic Methods

Bacteriological culture is the gold standard [3, 4]. Tissue samples are streaked onto blood agar or MacConkey agar and incubated at 37 degrees C under 5% CO2 for 18 to 24 hours [8]. P. multocida appears as small, gray, mucoid colonies with a characteristic musty odor. Gram staining reveals Gram-negative coccobacilli with bipolar staining after methylene blue staining [3, 7].

Biochemical profiling is used for confirmation. P. multocida is positive for oxidase, catalase, and indole, and ferments glucose, sucrose, and mannitol without gas production [10]. Capsular serotyping using the passive hemagglutination test distinguishes serogroups [10, 9].

Molecular Diagnostics

Molecular methods offer rapid and sensitive detection of P. multocida [21]. Polymerase chain reaction (PCR) assays targeting the kmt1 gene (species-specific) and capsular typing genes are widely used [3, 8, 21]. Loop-mediated isothermal amplification (LAMP) assays provide a field-deployable alternative to PCR, with comparable sensitivity and specificity [21]. Comparative evaluation of PCR and LAMP for detecting P. multocida in poultry shows both methods are reliable, but LAMP does not require thermocycling equipment [21].

Genomic characterization is increasingly employed for outbreak investigations and antimicrobial resistance profiling [13, 22, 9]. Whole-genome sequencing (WGS) enables the assignment of sequence types (e.g., ST20) and detection of resistance genes [22, 23]. Pulsed-field gel electrophoresis (PFGE) remains a useful tool for genotypic evaluation and epidemiological linkage of isolates [24].

Serological Assays

Enzyme-linked immunosorbent assays (ELISAs) are used to detect antibodies against P. multocida in chicken sera [25]. In-house indirect ELISAs have been developed and optimized for serosurveillance in unvaccinated and vaccinated flocks [25]. These assays are valuable for monitoring vaccine-induced immune responses [25, 26].

Differential Diagnosis

Fowl cholera must be differentiated from other bacterial septicemic diseases affecting poultry. Key differentials include avian influenza (highly pathogenic), Newcastle disease, Salmonella Gallinarum infection (fowl typhoid), Gallibacterium anatis infection, and Mycoplasma gallisepticum infection [18, 5, 27]. The 100% mortality pattern in acute outbreaks can clinically mimic exotic viral infections, necessitating rapid laboratory confirmation [2].

The following decision tree summarizes the diagnostic workflow for fowl cholera.

flowchart TD
    A[Clinical signs of acute septicemia or chronic localized lesions], > B[Post-mortem examination]
    B, > C{Sample collection}
    C, > D[Heart blood, liver, spleen, bone marrow]
    C, > E[Swabs from wattles, sinuses, joints]
    D, > F[Bacteriological culture on blood agar]
    E, > F
    F, > G{Colony morphology: gray, mucoid, musty odor}
    G, > H[Gram stain: Gram-negative coccobacilli, bipolar staining]
    H, > I[Biochemical confirmation: oxidase+, catalase+, indole+]
    I, > J{Advanced identification}
    J, > K[Species-specific PCR (kmt1)]
    J, > L[Capsular serotyping PCR or passive hemagglutination]
    J, > M[LAMP assay for field detection]
    J, > N[Whole-genome sequencing for typing and AMR genes]
    K, > O[Definitive diagnosis: Fowl cholera]
    L, > O
    M, > O
    N, > P[Epidemiological assignment: ST type, resistance profile]

Antimicrobial Resistance

Antimicrobial resistance in avian P. multocida is a growing global concern [22, 3, 8]. Comprehensive genomic characterization of isolates has revealed the acquisition of resistance genes via mobile genetic elements [22, 6]. Multidrug-resistant (MDR) strains have been reported from poultry and rabbits, showing resistance to tetracyclines, sulfonamides, beta-lactams, and aminoglycosides [8, 6].

An antibiogram profiling study in Ethiopia found that most P. multocida isolates from breeder chickens were susceptible to fluoroquinolones and ceftiofur, but resistant to penicillin and tetracycline [3]. Another study highlighted that the stringency of the antimicrobial policy and careful selection of antimicrobials are critical to mitigate resistance development [22, 4]. The presence of multiple resistance genes in the same isolate, such as tetH, blaROB-1, and sul2, has been documented in MDR strains [8, 6].

Treatment

Antimicrobial therapy should be based on in vitro susceptibility testing [3, 4]. Enrofloxacin, norfloxacin, and ceftiofur have demonstrated good in vitro activity against P. multocida isolates from poultry [3]. Tetracyclines (e.g., oxytetracycline, doxycycline) and sulfonamide-trimethoprim combinations are also used, though resistance is increasingly reported [8, 6].

Administration of antimicrobials via drinking water is the most practical route for flock treatment during an outbreak [4]. Early treatment during the acute phase can reduce mortality [3]. However, treatment may not eliminate the carrier state, and chronic infections often respond poorly [4]. The selection of antimicrobials must consider withdrawal periods to prevent drug residues in poultry meat and eggs [5].

Research into alternative therapeutic approaches includes the use of plant extracts. Wild Egyptian artichoke extract has shown in vitro antibacterial activity against P. multocida, suggesting potential for development as a natural control agent [28].

Control and Prevention

Biosecurity

Strict biosecurity is the cornerstone of fowl cholera control [1, 5]. All-in/all-out production systems, rodent and wild bird control, disinfection of facilities and equipment, and restricted visitor access are essential measures [1, 20]. Monitoring land cover and waterfowl activity near farms may help identify farms at elevated risk for outbreaks [20].

Vaccination

Vaccination is a critical component of fowl cholera control programs [29, 30, 10, 26]. Both inactivated (bacterin) and live attenuated vaccines are available [29, 31, 32].

Inactivated vaccines (bacterins) contain whole killed P. multocida cells and are often adjuvanted to enhance immunogenicity [30, 31]. Water-in-oil and aluminum hydroxide-adjuvanted bacterins induce strong humoral immune responses and protection [30, 26, 32]. Gel 01 hydrogel-adjuvanted inactivated vaccines have been shown to provide immunoprotection in chickens [30]. Gamma-irradiated inactivated vaccines formulated with various adjuvants induce antibody production and cytokine expression in chickens [26, 32].

Live attenuated vaccines are derived from serial passage of virulent strains and can provide broader immunity, including mucosal and cell-mediated responses [29]. The strain PMZ8, attenuated through serial passage in ducks, demonstrates reduced virulence while retaining immunogenicity [29]. Flagellin-based subunit vaccines targeting lipoprotein E (PlpE) have also been investigated [33, 34]. The inclusion of the native signal sequence of PlpE improves its immunogenicity when used as a recombinant subunit vaccine [34]. A trivalent outer membrane vesicle (OMV) vaccine approach, while primarily developed against Salmonella, demonstrates the expanding field of poultry vaccinology [27]. Vaccine efficacy is influenced by the LPS outer core composition and the presence of specific capsular antigens [10, 12].

The following table summarizes key fowl cholera vaccine types and their characteristics.

Eradication

On farms with recurrent fowl cholera outbreaks, depopulation, thorough cleaning and disinfection, followed by a rest period, may be necessary to eliminate the carrier state [1, 5]. Replacement stock should be sourced from P. multocida-free suppliers [5].

Conclusion

Fowl cholera remains a major threat to poultry production systems worldwide [1, 5]. Successful management requires integration of accurate and rapid molecular diagnostics, targeted antimicrobial therapy guided by susceptibility testing, rigorous biosecurity, and effective vaccination programs [29, 3, 4]. The emergence of multidrug-resistant P. multocida strains underscores the urgency of developing alternative control strategies, including novel vaccine platforms and plant-derived antimicrobials [22, 28, 8, 6].

References

[1] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. Br Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40960429/

[2] Miller I, Jerry C, Nguyen V, et al. 100% Mortality in Commercial Slow-Growing Broiler Chickens with Acute Fowl Cholera. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643942/

[3] Geda AM, Wendimu A, Lulie S, et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. Int J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40297765/

[4] Geda AM. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Vet Med Int. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39669206/

[5] Fasina YO, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) - Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poult Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38417326/

[6] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Vet World. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34840474/

[7] Shalaby AG, Bakry NR, El-Demerdash AS. Virulence attitude estimation of Pasteurella multocida isolates in embryonated chicken eggs. Arch Microbiol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34554268/

[8] El-Tarabili RM, Enany ME, Alenzi AM, et al. Unveiling resistance patterns, kmt1 sequence analyses, virulence traits, and antibiotic resistance genes of multidrug-resistant Pasteurella multocida retrieved from poultry and rabbits. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39948418/

[9] Hashish A, Johnson TJ, Ghanem M, et al. Complete genome sequences of eight Pasteurella multocida isolates representing all lipopolysaccharide outer core loci. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39365089/

[10] Semmate N, Bamouh Z, Elkarhat Z, et al. Isolation and Characterization of Pasteurella multocida A from an Outbreak in Turkeys in Morocco and Vaccine Preparation and Evaluation. Avian Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40643939/

[11] Omaleki L, Blackall PJ, Cuddihy T, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microb Genom. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35266868/

[12] Zhao X, Yang F, Shen H, et al. Immunogenicity and protection of a Pasteurella multocida strain with a truncated lipopolysaccharide outer core in ducks. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35236414/

[13] Islam MA, Haque ME, Iftehimul M, et al. Genomic profiling of Pasteurella multocida strains isolated from ISA Brown (Gallus gallus domesticus) in Bangladesh. Microbiol Resour Announc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920836/

[14] Gao P, Wang L, Wang S, et al. The activity of hyaD contributed to the virulence of avian Pasteurella multocida. Microb Pathog. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38960217/

[15] Smallman TR, Williams GC, Harper M, et al. Genome-Wide Investigation of Pasteurella multocida Identifies the Stringent Response as a Negative Regulator of Hyaluronic Acid Capsule Production. Microbiol Spectr. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35404102/

[16] Dassanayake RP, Briggs RE, Kaplan BS, et al. Pasteurella multocida filamentous hemagglutinin B1 (fhaB1) gene is not involved with avian fowl cholera pathogenesis in turkey poults. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40140814/

[17] Kubatzky KF. Pasteurella multocida toxin - lessons learned from a mitogenic toxin. Front Immunol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36591313/

[18] Gornatti-Churria CD, Jerry C, Ramsubeik S, et al. High mortality in a commercial turkey flock associated with coinfection by Pasteurella multocida and Mycoplasmoides (Mycoplasma) gallisepticum. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40996859/

[19] Xiao J, Li Y, Hu Z, et al. Characterization of Pasteurella multocida isolated from ducks in China from 2017 to 2019. Microb Pathog. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34534643/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[20] Ouyang L, Campler MR, Wong S, et al. Exploring the Impact of Land Cover on the Occurrence of Ornithobacteriosis and Fowl Cholera: A Case-Case Study. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39943166/

[21] Poussard M, Pant SD, Huang J, et al. Comparative evaluation of PCR and loop-mediated isothermal amplification (LAMP) assays for detecting Pasteurella multocida in poultry. N Z Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39448061/

[22] Miao F, Dai B, Li Z, et al. Antimicrobial resistance and genomic characteristics of avian Pasteurella multocida. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637789/

[23] Allen JL, Bushell RN, Noormohammadi AH, et al. Pasteurella multocida ST20 is widespread in Australian poultry farms and may infect wild waterbirds. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38228079/

[24] Tabatabaei M, Janparvar A, Motamedifar M. Genotypic evaluation of Pasteurella multocida isolated from cattle and sheep by pulsed-field gel electrophoresis. Vet Res Forum. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37181852/

[25] Beyene D, Shite A, Getachew B. Development and optimization of in-house made indirect ELISA kit for the detection of antibodies against Pasteurella multocida in chicken. BMC Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724974/

[26] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Front Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40103817/

[27] Maiti S, Halder P, Banerjee S, et al. Development of a novel trivalent invasive non-typhoidal Salmonella outer membrane vesicles based vaccine against salmonellosis and fowl typhoid in chickens. Immunobiology. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35121180/

[28] Wahdan A, Elsebai MF, Elhaig MM, et al. Innovative use of wild Egyptian artichoke extract to control fowl cholera in vitro. Vet World. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40182829/

[29] Ji X, Meng Y, Yang H, et al. Attenuation mechanisms and vaccine potential of the serial passage-derived Pasteurella multocida strain PMZ8 in ducks. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41747463/

[30] Chen J, Sun Y, Hu Y, et al. Evaluation of the immunoprotective effect of gel 01 hydrogel inactivated vaccine against Pasteurella multocida infection in chickens. Microb Pathog. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40934985/

[31] Ghadimipour R, Ghorbanpoor M, Gharibi D, et al. Effects of Selected Adjuvants on Immunogenicity and Protectivity of Pasteurella multocida Bacterin Vaccine in Chickens. Arch Razi Inst. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/35096310/

[32] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Front Immunol. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34917086/

[33] Chung YC, Cheng LT, Chu CY, et al. Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine. Avian Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39400212/

[34] Cheng LT, Chu CY, Vu-Khac H, et al. Signal sequence contributes to the immunogenicity of Pasteurella multocida lipoprotein E. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36423524/

[35] Bathobakae L, Cho H, Philip S, et al. Friend Turned Foe: Pasteurella multocida Bacteremia Following a Scratch by an Adopted Pekin Duck. J Investig Med High Impact Case Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40110910/